BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 28
• 29
• 30
• 31

• Drug Development

  Opsona Therapeutics Ltd. Initiates a Phase II Study With OPN-305, a First-in Class Monoclonal Antibody That Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function

  May 7, 2013

   · 

  1 min read
• Business

  VIVUS, Inc. Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca PLC, to Serve as Senior Advisor

  May 7, 2013

   · 

  1 min read
• Business

  Raptor Pharmaceutical Inc. Licenses Intellectual Property for Rett Syndrome From French Research Institutes

  May 7, 2013

   · 

  1 min read
• Vical Incorporated to Present at May Investor Conferences

  May 7, 2013

   · 

  1 min read
• Pharm Country

  Sitrof Safety Capture Solutions Complete EMC Certification Process

  May 7, 2013

   · 

  1 min read
• BioMidwest

  Utah Medical Products, Inc. Announces Quarterly Dividend

  May 7, 2013

   · 

  1 min read
• Nuvo Research Inc. to Complete Share Consolidation

  May 7, 2013

   · 

  5 min read
• Business

  Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for First Quarter 2013 – Results From 1 January to 31 March, 2013

  May 7, 2013

   · 

  1 min read
• FDA

  Congenix Gains CE Mark for ReLASV® Antigen Rapid Test

  May 7, 2013

   · 

  5 min read
• Business

  Supernus Pharmaceuticals Announces First Quarter 2013 Earnings Conference Call and Webcast

  May 7, 2013

   · 

  1 min read